Jiang Zhu Selected Research

Leukemia

1/2022	IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia.
11/2019	Prognostic significance of CXCR4 expression in acute myeloid leukemia.
1/2019	Leukemic IL-17RB signaling regulates leukemic survival and chemoresistance.
11/2017	All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
1/2017	Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.
1/2017	Activation of G0S2 is coordinated by recruitment of PML/RARα and C/EBPε to its promoter during ATRA-induced APL differentiation.
8/2015	Valproic Acid Ameliorates Graft-versus-Host Disease by Downregulating Th1 and Th17 Cells.
4/2014	An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.
2/2014	RIG-I modulates Src-mediated AKT activation to restrain leukemic stemness.
12/2012	The regulation of normal and leukemic hematopoietic stem cells by niches.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiang Zhu Research Topics

Disease

96	Neoplasms (Cancer) 07/2022 - 02/2003
33	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 10/2002
23	Pain (Aches) 12/2021 - 08/2008
23	Dysmenorrhea (Menstrual Pain) 01/2019 - 01/2008
22	Neoplasm Metastasis (Metastasis) 06/2022 - 03/2006
18	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2012
16	Inflammation (Inflammations) 01/2022 - 11/2009
15	Infections 06/2022 - 08/2010
14	Lung Neoplasms (Lung Cancer) 06/2022 - 06/2004
13	Leukemia 01/2022 - 12/2004
13	Carcinoma (Carcinomatosis) 12/2021 - 12/2004
11	Carcinogenesis 01/2022 - 11/2012
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2011
8	Lymphatic Metastasis 01/2021 - 07/2007
8	Reperfusion Injury 01/2021 - 06/2010
7	Autism Spectrum Disorder 07/2022 - 01/2018
7	Disease Progression 06/2022 - 08/2013
7	Sepsis (Septicemia) 01/2022 - 01/2014
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 07/2008
7	Ischemia 01/2021 - 04/2009
7	Fibrosis (Cirrhosis) 11/2020 - 06/2011
6	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2016
6	Osteosarcoma (Osteogenic Sarcoma) 10/2021 - 07/2010
6	Adenocarcinoma of Lung 01/2021 - 04/2008
6	Acute Promyelocytic Leukemia 01/2020 - 06/2000
5	Wounds and Injuries (Trauma) 06/2022 - 08/2008
5	Nausea 06/2022 - 06/2004
5	Vomiting 06/2022 - 06/2004
5	Vitamin A Deficiency 10/2021 - 01/2018
5	Autistic Disorder (Autism) 01/2021 - 01/2018
5	Infarction (Infarctions) 01/2021 - 01/2014
5	Myocardial Infarction 04/2020 - 06/2010
5	Stomach Neoplasms (Stomach Cancer) 10/2018 - 03/2006
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2005
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
4	Esophageal Squamous Cell Carcinoma 04/2021 - 09/2016
4	Brain Ischemia (Cerebral Ischemia) 01/2021 - 12/2012
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2016
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2014
4	Postoperative Pain 01/2021 - 08/2017
4	Hyperthermia 06/2019 - 08/2005
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2018 - 06/2004
4	Abdominal Pain (Pain, Abdominal) 01/2018 - 02/2007
4	Hypoxia (Hypoxemia) 12/2017 - 06/2013
3	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022 - 09/2017

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2004
18	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2014
14	Pharmaceutical PreparationsIBA 01/2022 - 05/2005
13	Analgesics (Analgesic Drugs)IBA 01/2019 - 06/2010
12	Messenger RNA (mRNA)IBA 01/2022 - 03/2006
10	arginyl- threonyl- prolyl- prolyl- prolyl- seryl- glycine (SP 6)IBA 01/2019 - 02/2007
9	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2014
9	VaccinesIBA 10/2021 - 04/2015
8	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 10/2002
8	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 02/2014
8	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2016
8	Circular RNAIBA 01/2022 - 01/2020
8	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2016
8	Peptides (Polypeptides)IBA 12/2021 - 10/2010
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2004
7	CytokinesIBA 01/2022 - 11/2009
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2005
7	AntibodiesIBA 01/2019 - 04/2009
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 07/2009
6	AntigensIBA 09/2021 - 01/2013
5	Immune Checkpoint InhibitorsIBA 06/2022 - 07/2019
5	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2021
5	Long Noncoding RNAIBA 01/2022 - 01/2020
5	salicylhydroxamic acid (SHAM)IBA 12/2021 - 08/2008
5	Neutralizing AntibodiesIBA 10/2021 - 09/2017
5	NF-kappa B (NF-kB)IBA 06/2021 - 12/2004
5	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 12/2004
5	SurvivinIBA 01/2020 - 09/2011
5	Biological ProductsIBA 12/2019 - 07/2008
5	Retinaldehyde (Retinal)IBA 05/2019 - 09/2014
4	Phosphotransferases (Kinase)IBA 01/2022 - 12/2010
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 11/2009
4	ProteomeIBA 01/2022 - 07/2015
4	Pemetrexed (MTA)FDA Link 01/2022 - 11/2011
4	Tumor Biomarkers (Tumor Markers)IBA 09/2021 - 01/2014
4	LipopolysaccharidesIBA 01/2021 - 09/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 08/2014
4	Broadly Neutralizing AntibodiesIBA 01/2021 - 04/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2018 - 05/2008
4	estradiol 3-benzoate (estradiol benzoate)IBA 02/2012 - 06/2010
4	Oxytocin (Pitocin)FDA LinkGeneric 10/2011 - 06/2010
3	Histones (Histone)IBA 01/2022 - 01/2010

Therapy/Procedure

44	Therapeutics 01/2022 - 12/2004
29	Drug Therapy (Chemotherapy) 06/2022 - 08/2005
17	Acupuncture Points (Acupuncture Point) 04/2018 - 12/2009
15	Electroacupuncture 01/2019 - 11/2005
10	Radiotherapy 01/2022 - 07/2004
9	Percutaneous Collagen Induction 01/2019 - 10/2010
8	Lasers (Laser) 12/2021 - 01/2010
6	Aftercare (After-Treatment) 12/2021 - 02/2007
6	Analgesia 01/2019 - 02/2011
4	Acupuncture Therapy 01/2022 - 02/2014
4	Chemoradiotherapy 01/2020 - 06/2010
4	Subcutaneous Injections 02/2012 - 10/2010
3	Immunotherapy 06/2022 - 07/2019